International Journal of Cancer
Wiley · US · ISSN 00207136
动向摘要
The journal is publishing less and drawing fewer citations per paper.
Annual output went from 779 to 568 papers. If rapid dissemination matters, consider whether a smaller recent volume changes visibility. Field-weighted citation impact moved from 3.15 to 1.99. Expect that typical citation performance for new papers may be closer to the journal's recent lower level. Head and Neck Cancer Studies rose from 0.0% to 5.7% of what the journal runs. Authors working on head and neck cancer may find more topical fit than before. Recent titles increasingly carry scp · immunochemotherapy · apatinib · cohort. If your manuscript uses those methods or drugs, it may align with current article themes.
引用指标
基于 Scopus 与 OpenAlex 引用图谱。本站不提供 Clarivate 的 JCR 影响因子。
发文量与被引表现
发文量增长时被引表现是否同步。
主题变化
对比近 24 个月(2024-09 – 2026-08)与此前 24 个月(2022-09 – 2024-08)的占比。
- Head and Neck Cancer Studies0.0%→5.7%+5.7%p此前近期
- Cervical Cancer and HPV Research12.7%→16.7%+4.1%p此前近期
- Breast Cancer Treatment Studies0.0%→3.9%+3.9%p此前近期
- Lung Cancer Treatments and Mutations0.0%→2.9%+2.9%p此前近期
- Legal and Policy Issues6.2%→0.0%−6.2%p此前近期
- Epigenetics and DNA Methylation4.5%→0.0%−4.5%p此前近期
- COVID-19 and healthcare impacts4.2%→0.0%−4.2%p此前近期
- Social and Behavioral Studies4.0%→0.0%−4.0%p此前近期
- Glioma Diagnosis and Treatment3.5%→0.0%−3.5%p此前近期
近期高频术语
近期论文标题中相较以往显著增加的表述。
作者国家构成
将近 24 个月(2024-09 – 2026-08)与此前 24 个月(2022-09 – 2024-08)并列显示。
- CN20.1%→24.3%+4.2%p此前近期
- US25.1%→21.6%−3.5%p此前近期
- DE12.9%→14.7%+1.8%p此前近期
- GB11.4%→10.1%−1.2%p此前近期
- FR8.8%→9.4%+0.7%p此前近期
- NL8.2%→8.6%+0.4%p此前近期
机构发文 Top 5
2018 – 2026 期间在该期刊发表论文的前 5 家机构。
- Inserm220篇
近期发表论文
19按发表日期最新的 19 篇,并非全部。
高被引论文
202018 – 2026 期间被引最高的 20 篇。
相似期刊
数据截至 2026-09-05